Total investments

18

Average round size

19M

Portfolio companies

14

Rounds per year

1.64

Lead investments

4

Follow on index

0.22

Exits

6

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyAnalyticsHealth CareHealth DiagnosticsMedical DeviceMedicalPharmaceuticalTherapeuticsBiopharmaPrivacy

Summary

In 2011 was created BDC Healthcare Venture, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Montru00e9al. The venture was found in North America in Canada.

We also calculated 2 valuable employees in our database.

Among the various public portfolio startups of the fund, we may underline Clementia Pharmaceuticals, Repare Therapeutics, Thrasos We can highlight the next thriving fund investment areas, such as Medical, Therapeutics. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada.

The standard case for the fund is to invest in rounds with 5 partakers. Despite the BDC Healthcare Venture, startups are often financed by Yaletown Partners, CTI Life Sciences Fund, BDC Venture Capital. The meaningful sponsors for the fund in investment in the same round are CTI Life Sciences Fund, Yaletown Partners, Fonds de solidaritu00e9 FTQ. In the next rounds fund is usually obtained by Yaletown Partners, Fonds de solidaritu00e9 FTQ, CTI Life Sciences Fund.

The fund is constantly included in 2-6 investment rounds annually. Considering the real fund results, this Corporate Investor is 3 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2015. Opposing the other organizations, this BDC Healthcare Venture works on 2 percentage points more the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2017.

Show more

Investments analytics

Analytics

Total investments
18
Lead investments
4
Exits
6
Rounds per year
1.64
Follow on index
0.22
Investments by industry
  • Health Care (12)
  • Biotechnology (11)
  • Medical Device (7)
  • Medical (6)
  • Therapeutics (5)
  • Show 17 more
Investments by region
  • Canada (17)
  • United States (1)
Peak activity year
2015
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
15
Avg. valuation at time of investment
92M
Group Appearance index
0.94
Avg. company exit year
8
Avg. multiplicator
8.51
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Fischer Block 04 Sep 2018 Energy, Predictive Analytics, Sensor Early Stage Venture 3M United States, Pennsylvania
Milestone Pharmaceuticals 15 Jun 2015 Biotechnology, Drug Discovery, Pharmaceuticals, Health Care, Therapeutics Early Stage Venture 17M Quebec, Montreal, Canada
Monteris Medical 13 Nov 2014 Health Care, Medical Device, Medical Early Stage Venture 30M United States, Minnesota

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.